Get the Stockscreener App
73.05
0.11%
-0.08
After Hours:
73.05
Mirum Pharmaceuticals Inc stock is traded at $73.05, with a volume of 104.63K.
It is down -0.11% in the last 24 hours and up +3.60% over the past month.
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
See More
Previous Close:
$73.13
Open:
$73.36
24h Volume:
104.63K
Relative Volume:
0.16
Market Cap:
$3.75B
Revenue:
$379.25M
Net Income/Loss:
$-77.34M
P/E Ratio:
-45.31
EPS:
-1.6122
Net Cash Flow:
$-27.87M
1W Performance:
+2.93%
1M Performance:
+3.60%
6M Performance:
+67.05%
1Y Performance:
+56.59%
1-Day Range:
$72.48
$73.36
1-Week Range:
$70.62
$73.96
52-Week Range:
$36.88
$78.54
Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile
Name
Mirum Pharmaceuticals Inc
Sector
Industry
Phone
650-667-4085
Address
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
Compare MIRM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MIRM
Mirum Pharmaceuticals Inc
|
73.05 | 3.76B | 379.25M | -77.34M | -27.87M | -1.6122 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-24-25 | Initiated | TD Cowen | Buy |
| Aug-11-25 | Resumed | Stifel | Buy |
| May-19-25 | Resumed | H.C. Wainwright | Buy |
| Apr-17-24 | Initiated | Stifel | Buy |
| Dec-18-23 | Reiterated | H.C. Wainwright | Buy |
| Nov-20-23 | Resumed | JP Morgan | Overweight |
| Nov-13-23 | Initiated | Morgan Stanley | Overweight |
| Oct-24-23 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-17-23 | Resumed | Evercore ISI | Outperform |
| Sep-20-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-01-22 | Initiated | Citigroup | Buy |
| Sep-20-21 | Initiated | JP Morgan | Overweight |
| Aug-07-20 | Upgrade | Raymond James | Outperform → Strong Buy |
| Aug-03-20 | Initiated | H.C. Wainwright | Buy |
| Jul-31-20 | Initiated | Piper Sandler | Overweight |
| Jun-25-20 | Initiated | Robert W. Baird | Outperform |
| Aug-12-19 | Initiated | Citigroup | Buy |
| Aug-12-19 | Initiated | Evercore ISI | Outperform |
| Aug-12-19 | Initiated | Guggenheim | Buy |
| Aug-12-19 | Initiated | ROTH Capital | Buy |
| Aug-12-19 | Initiated | Raymond James | Outperform |
View All
Mirum Pharmaceuticals Inc Stock (MIRM) Latest News
Is Vantage Knowledge Academy Limited a Top Growth Stock to Watch in YEARREITs Market Trends & Affordable Portfolio Growth - earlytimes.in
Mirum Pharmaceuticals Inc Stock Analysis and ForecastShort Interest Overview & Free Turn Volatility To Profit - earlytimes.in
How Mirum Pharmaceuticals Inc. (MIRM) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Mirum aims for $500M–$510M 2025 revenue as cash flow turns positive and pivotal trial readouts approach - MSN
Is Mirum Pharmaceuticals Running Ahead of Itself After Pipeline Progress News and a 74% Rally? - simplywall.st
How Mirum Pharmaceuticals Inc. stock compares to growth peersLong Setup & Precise Swing Trade Alerts - BỘ NỘI VỤ
Mirum Pharmaceuticals (MIRM): Exploring Valuation After Steady Momentum and Pipeline Developments - Yahoo Finance
Will Mirum Pharmaceuticals Inc. stock pay special dividends2025 Geopolitical Influence & Technical Entry and Exit Tips - moha.gov.vn
Mirum Pharmaceuticals Insider Sold Shares Worth $3,500,000, According to a Recent SEC Filing - MarketScreener
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences - Business Wire
First Week of July 2026 Options Trading For Mirum Pharmaceuticals (MIRM) - Nasdaq
Does Mirum Pharmaceuticals (NASDAQ:MIRM) Have A Healthy Balance Sheet? - 富途牛牛
Mirum Pharmaceuticals Reports Strong Q3 2025 Growth - MSN
Cash from financing activities of Mirum Pharmaceuticals, Inc. – HAM:08D - TradingView
Chmn Grey Files To Sell 50,000 Of Mirum Pharmaceuticals Inc [MIRM] - TradingView
Is Mirum Pharmaceuticals Inc. stock safe for conservative investors2025 Performance Recap & Comprehensive Market Scan Insights - newser.com
Mirum Pharmaceuticals fosters rare liver disease collaborations at NASPGHAN 2025 - Traders Union
CEO Peetz Acquires 19,133 Of Mirum Pharmaceuticals Inc [MIRM] - TradingView
[Form 4] Mirum Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan
Will Mirum Pharmaceuticals Inc. (08D) stock benefit from mergersMarket Growth Review & Accurate Technical Buy Alerts - newser.com
Is Mirum Pharmaceuticals Inc. stock supported by innovation pipelineJuly 2025 Levels & High Accuracy Buy Signal Tips - newser.com
Will Mirum Pharmaceuticals Inc. see short term momentum2025 AllTime Highs & Reliable Trade Execution Plans - newser.com
Why Mirum Pharmaceuticals Inc. (08D) stock attracts HNW investorsPortfolio Update Report & Breakout Confirmation Trade Signals - newser.com
Why Mirum Pharmaceuticals Inc. stock remains undervaluedJuly 2025 Selloffs & Smart Swing Trading Techniques - newser.com
Is Mirum Pharmaceuticals Inc. (08D) stock worth buying before Fed actionProduct Launch & Safe Entry Trade Signal Reports - newser.com
Is Mirum Pharmaceuticals Inc. stock overvalued by current metrics2025 Sector Review & Low Risk High Reward Ideas - newser.com
Will Mirum Pharmaceuticals Inc. (08D) stock keep high P E multiples2025 Biggest Moves & Precise Entry and Exit Recommendations - newser.com
Mirum Pharmaceuticals Inc. (MIRM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
(MIRM) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
Mirum Pharmaceuticals: Strategic Positioning and Strong Defense Justify Buy Rating - TipRanks
Is Mirum Pharmaceuticals Inc. stock supported by strong cash flows2025 Top Decliners & Risk Controlled Daily Plans - newser.com
Mirum Pharmaceuticals to File Patent Infringement Lawsuit Against Sandoz - MarketScreener
Mirum Pharmaceuticals receives notice of generic challenge to Livmarli patents - Investing.com
[8-K] Mirum Pharmaceuticals, Inc. Reports Material Event | MIRM SEC FilingForm 8-K - Stock Titan
A Look at Mirum Pharmaceuticals's Valuation Following Profit Surge and Raised 2025 Guidance - simplywall.st
How Mirum Pharmaceuticals Inc. (08D) stock valuation compares with sectorWeekly Earnings Recap & Daily Oversold Bounce Ideas - newser.com
Why Mirum Pharmaceuticals Inc. stock is popular among millennials2025 Valuation Update & Entry Point Confirmation Signals - Fundação Cultural do Pará
What analysts say about Mirum Pharmaceuticals Inc stockShort-Term Trading Alerts & High Yield Portfolio Picks - earlytimes.in
Mirum Pharmaceuticals Inc Stock (MIRM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
1.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):